The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Type I interferons in infectious disease
Open accessAbstract
Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If type I IFNs are present early and properly localized to sites of infection, they can effectively limit viral propagation, as type I IFNs are responsible for optimal activation of macrophages, antigen presentation by DCs, and enhanced anti-viral effector T cell responses106.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
Schoenborn, J. R., & Wilson, C. B. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,709
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors
Honda, K., Takaoka, A., & Taniguchi, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.009 · Cited by 1,386
The IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali‐Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 995
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993
Bon, A. L., Schiavoni, G., D’Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 973
Prokunina‐Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H. L., Hergott, D., Porter-Gill, P. A., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 929
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 888
Goubau, D., Deddouche, S., & Sousa, C. R. E. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 875
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Bon, A. L., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D. R., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 816
Liu, L., Okada, S., Kong, X., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschké, P., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 816
Paludan, S. R., & Bowie, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.004 · Cited by 795
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 789
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J. W., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 763
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 757
Self-citationPersistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732
TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria
Rathinam, V. A. K., Vanaja, S. K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L. M., Leong, J. M., & Fitzgerald, K. A. (2012) · Cell · doi:10.1016/j.cell.2012.07.007 · Cited by 729
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709
STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A., der Graaf, C. A. A. S.-V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 684
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 666
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Pucchio, T. D., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 644
Curtsinger, J., Valenzuela, J. O., Agarwal, P., Lins, D. C., & Mescher, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4465 · Cited by 633
Nguyen, K. B., Salazar‐Mather, T. P., Dalod, M., VanDeusen, J. B., Wei, X., Liew, F. Y., Caligiuri, M. A., Durbin, J. E., & Biron, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4279 · Cited by 606
Manca, C., Tsenova, L., Bergtold, A., Freeman, S. L., Tovey, M. G., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 590
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature reviews. Immunology · doi:10.1038/nri3210 · Cited by 588
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) · Science · doi:10.1126/science.1224026 · Cited by 572
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 565
Bromberg, J., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E., Jr. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 555
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J. B., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 548
Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1
Broz, P., Ruby, T., Belhocine, K., Bouley, D. M., Kayagaki, N., Dixit, V. M., & Monack, D. M. (2012) · Nature · doi:10.1038/nature11419 · Cited by 535
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 505
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
Brinkmann, V., Geiger, T. M., Alkan, Ş. Ş., & Heusser, C. H. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1655 · Cited by 505
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O’Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B. J., Perry, A. K., Nguyen, B. D., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 499
Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M., O’Shea, J. J., & Biron, C. A. (2002) · Science · doi:10.1126/science.1074900 · Cited by 495
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 492
Ganal, S. C., Sanos, S. L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.020 · Cited by 484
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S., Wilson, M. S., Cheever, A. W., Kugler, D. G., Hieny, S. E., Caspar, P., Núñez, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904189 · Cited by 472
Self-citationInterferon α/β and Interleukin 12 Responses to Viral Infections
Dalod, M., Salazar‐Mather, T. P., Malmgaard, L., Lewis, C. A., Asselin‐Paturel, C., Brière, F., Trinchieri, G., & Biron, C. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011672 · Cited by 462
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Utay, N. S., Bosinger, S. E., Estes, J. D., Zhu, R. T., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Nganou‐Makamdop, K., Prete, G. Q. D., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 458
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O’Riordan, M. X., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 451
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S. R., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 447
Stanley, S. A., Johndrow, J. E., Manzanillo, P. S., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 439
Robinson, N., McComb, S., Mulligan, R., Dudani, R., Krishnan, L., & Sad, S. (2012) · Nature Immunology · doi:10.1038/ni.2397 · Cited by 438
Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.002 · Cited by 418
Self-citationType I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
Carrero, J. A., Calderón, B., & Unanue, E. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040769 · Cited by 397
Pathogenic potential of interferon αβ in acute influenza infection
Davidson, S., Crotta, S., McCabe, T. M., & Wack, A. (2014) · Nature Communications · doi:10.1038/ncomms4864 · Cited by 386
Self-citationMandl, J. N., Barry, A. P., Vanderford, T. H., Kozyr, N. L., Chavan, R., Klucking, S., Barrat, F. J., Coffman, R. L., Staprans, S. I., & Feinberg, M. B. (2008) · Nature Medicine · doi:10.1038/nm.1871 · Cited by 382
Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D. J., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly‐Scumpia, K. M., Chun, R. F., Iyer, S. S., et al. (2013) · Science · doi:10.1126/science.1233665 · Cited by 375
Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J. D., Röllinghoff, M., Gresser, I., & Bogdan, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80460-4 · Cited by 368
Bon, A. L., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2074 · Cited by 367
TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway
Moynagh, P. N. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.009 · Cited by 336
Zhang, S., Boisson‐Dupuis, S., Chapgier, A. L. A., Yang, K., Bustamante, J. C., Puel, A., Pïcard, C., Abel, L., Jouanguy, E., & Casanova, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00698.x · Cited by 334
Inborn Errors of Human JAKs and STATs
Casanova, J., Holland, S. M., & Notarangelo, L. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.016 · Cited by 333
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J., Paludan, S. R., Klucher, K. M., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 326
Henry, T., Brotcke, A., Weiss, D. S., Thompson, L. J., & Monack, D. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062665 · Cited by 323
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection
Liehl, P., Zuzarte-Luís, V., Chan, J., Zillinger, T., Baptista, F., Carapau, D., Konert, M., Hanson, K. K., Carret, C., Lassnig, C., et al. (2014) · Nature Medicine · doi:10.1038/nm.3424 · Cited by 313
Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs
Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., & Fukuhara, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2961 · Cited by 310
Human gene expression profiles of susceptibility and resistance in tuberculosis
Maertzdorf, J., Repsilber, D., Parida, S. K., Stanley, K., Roberts, T., Black, G. F., Walzl, G., & Kaufmann, S. H. E. (2010) · Genes and Immunity · doi:10.1038/gene.2010.51 · Cited by 304
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Cousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 299
Manca, C., Tsenova, L., Freeman, S. L., Barczak, A. K., Tovey, M. G., Murray, P. J., Barry, C. E., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 295
Influenza Virus-Susceptible Mice Carry Mx Genes with a Large Deletion or a Nonsense Mutation
Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G., & Haller, O. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4518-4523.1988 · Cited by 294
The regulation of inflammation by interferons and their STATs
Rauch, I., Müller, M. M., & Decker, T. (2013) · JAK-STAT · doi:10.4161/jkst.23820 · Cited by 292
Antonelli, L. R. D. V., Rothfuchs, A. G., Gonçalves, R., Roffê, E., Cheever, A. W., Báfica, A. L. B., Salazar, A. Μ., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Self-citationPandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292
Cousens, L. P., Peterson, R. L., Hsu, S., Dorner, A. J., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernández-Sesma, A., Lee, C., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanović, S., García‐Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Bon, A. L., Durand, V., Kamphuis, E., Thompson, C., Bulfone‐Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4682 · Cited by 283
NOD1 and NOD2 Signaling in Infection and Inflammation
Moreira, L. O., & Zamboni, D. S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00328 · Cited by 282
The Role of Interferon in Influenza Virus Tissue Tropism
García‐Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., & Durbin, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8550-8558.1998 · Cited by 281
Nakamura, S., Davis, K. M., & Weiser, J. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57762 · Cited by 280
Soudja, S. M., Ruiz, A. L., Marie, J. C., & Lauvau, G. S. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.029 · Cited by 274
Tripartite-motif proteins and innate immune regulation
McNab, F. W., Rajsbaum, R., Stoye, J. P., & O’Garra, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.021 · Cited by 272
Self-citationWatanabe, T., Asano, N., Fichtner‐Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y. M., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39481 · Cited by 265
Crotta, S., Davidson, S., Mahlakõiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 263
Self-citationViral tricks to grid-lock the type I interferon system
Versteeg, G. A., & García‐Sastre, A. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.009 · Cited by 262
Zhang, Y., Zhao, Y., Li, N., Peng, Y., Giannoulatou, E., Jin, R., Yan, H., Wu, H., Liu, J., Liu, N., et al. (2013) · Nature Communications · doi:10.1038/ncomms2433 · Cited by 262
Parlato, S., Santini, S. M., Lapenta, C., Pucchio, T. D., Logozzi, M., Spada, M., Giammarioli, A. M., Malorni, W., Fais, S., & Belardelli, F. (2001) · Blood · doi:10.1182/blood.v98.10.3022 · Cited by 259
Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells
Chaperot, L., Blum, A., Manches, O., Lui, G., Angel, J., Molens, J., & Plumas, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.248 · Cited by 256
Ordway, D. J., Henao-Tamayo, M. I., Harton, M. R., Palanisamy, G. S., Troudt, J. M., Shanley, C. A., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 255
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F. F., Gambuzza, M. E., Macrì, G., Ruggeri, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3126 · Cited by 254
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus.
Horisberger, M. A., Staeheli, P., & Haller, O. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1910 · Cited by 249
Novikov, A., Cardone, M., Thompson, R. W., Shenderov, K., Kirschman, K. D., Mayer-Barber, K. D., Myers, T. G., Rabin, R. L., Trinchieri, G., Sher, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100926 · Cited by 246
Self-citationCliff, J. M., Lee, J., Constantinou, N., Cho, J.-E., Clark, T. G., Ronacher, K., King, E. C., Lukey, P. T., Duncan, K., van Helden, P. D., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis499 · Cited by 239
Högner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., Walmrath, H., Bodner, J., Gattenlöhner, S., Lewe-Schlosser, P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003188 · Cited by 237
Kohlmeier, J. E., Cookenham, T. S., Roberts, A. D., Miller, S. C., & Woodland, D. L. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.016 · Cited by 237
Effects of IL-12 on the response and susceptibility to experimental viral infections.
Orange, J. S., Wolf, S., & Biron, C. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1253 · Cited by 235
Ottenhoff, T. H. M., Dass, R. H., Yang, N., Zhang, M. M., Wong, H. E. E., Sahiratmadja, E., Khor, C. C., Alisjahbana, B., van Crevel, R., Marzuki, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045839 · Cited by 235
Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
Xu, H. C., Grusdat, M., Pandyra, A. A., Polz, R., Huang, J., Sharma, P., Deenen, R., Köhrer, K., Rahbar, R., Diefenbach, A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.004 · Cited by 232
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M. R., Xénarios, I., von Laer, D., Kalinke, U., Vivier, É., Jonjić, S., & Oxenius, A. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.003 · Cited by 229
Sung, J. H., Zhang, H., Moseman, E. A., Álvarez, D., Iannacone, M., Henrickson, S. E., de la Torre, J. C., Groom, J. R., Luster, A. D., & von Andrian, U. H. (2012) · Cell · doi:10.1016/j.cell.2012.08.015 · Cited by 228
Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen
Leber, J. H., Crimmins, G. T., Raghavan, S., Meyer-Morse, N., Cox, J. S., & Portnoy, D. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040006 · Cited by 226
Herbeuval, J. (2005) · Blood · doi:10.1182/blood-2005-03-1243 · Cited by 225
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 224
Heer, A. K., Shamshiev, A. T., Donda, A., Uematsu, S., Akira, S., Köpf, M., & Marsland, B. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2182 · Cited by 212
Havenar‐Daughton, C., Kolumam, G. A., & Murali‐Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3315 · Cited by 211
McNab, F. W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Մարտիրոսյան, Ա., Ghilardi, N., Saraiva, M., & O’Garra, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401088 · Cited by 211
Self-citationHahm, B., Trifilo, M. J., Zúñiga, E. I., & Oldstone, M. B. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.005 · Cited by 210
Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ
Rayamajhi, M., Humann, J., Penheiter, K. L., Andreasen, K., & Lenz, L. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091746 · Cited by 209
Coulombe, F., Jaworska, J., Verway, M. J., Tzelepis, F., Massoud, A. H., Gillard, J., Wong, G., Kobinger, G., Xing, Z., Couture, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.013 · Cited by 207
Orange, J. S., Salazar‐Mather, T. P., Opal, S. M., Spencer, R. L., Miller, A. H., McEwen, B. S., & Biron, C. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.901 · Cited by 207
Kawashima, T., Kosaka, A., Yan, H., Guo, Z., Uchiyama, R., Fukui, R., Kaneko, D., Kumagai, Y., You, D., Carreras, J., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.024 · Cited by 206
Agarwal, P., Raghavan, A., Nandiwada, S. L., Curtsinger, J., Bohjanen, P. R., Mueller, D. L., & Mescher, M. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900592 · Cited by 203
Protective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiß, S., & Staeheli, P. (2006) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201
Attrition of Bystander CD8 T Cells during Virus-Induced T-Cell and Interferon Responses
McNally, J. M., Zarozinski, C. C., Lin, M., Brehm, M. A., Chen, H. D., & Welsh, R. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5965-5976.2001 · Cited by 199
Thompson, L. J., Kolumam, G. A., Thomas, S., & Murali‐Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1746 · Cited by 197
del Fresno, C., Soulat, D., Roth, S., Blazek, K. D., Udalova, I. A., Sancho, D., Ruland, J., & Ardavín, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.010 · Cited by 196
Rotger, M., Dalmau, J., Rauch, A., McLaren, P. J., Bosinger, S. E., Martínez, R., Utay, N. S., Roque, A., Liebner, J. C., Battegay, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45235 · Cited by 196
The Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice
Price, G. E., Gaszewska-Mastalarz, A., & Moskophidis, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3996-4003.2000 · Cited by 195
Hardy, A. W., Graham, D. R. M., Shearer, G. M., & Herbeuval, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707244104 · Cited by 194
Li, W., Moltedo, B., & Moran, T. M. (2012) · Journal of Virology · doi:10.1128/jvi.01269-12 · Cited by 191
Herbeuval, J., Nilsson, J., Boasso, A., Hardy, A. W., Kruhlak, M. J., Anderson, S. A., Dolan, M. J., Dy, M., Andersson, J., & Shearer, G. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600363103 · Cited by 186
Coro, E. S., Chang, W. L. W., & Baumgarth, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4343 · Cited by 184
IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties
Witte, K., Witte, E., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.002 · Cited by 179
Miyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W., & Biron, C. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070401 · Cited by 176
Aichele, P., Unsoeld, H., Koschella, M., Schweier, O., Kalinke, U., & Vucikuja, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4525 · Cited by 172
Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
Desvignes, L., Wolf, A. J., & Ernst, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200255 · Cited by 172
Martinez, J., Huang, X., & Yang, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1592 · Cited by 168
Impairment of T and B Cell Development by Treatment with a Type I Interferon
Lin, Q., Dong, C., & Cooper, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.79 · Cited by 163
Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response
Swanson, C. L., Wilson, T. J., Strauch, P., Colonna, M., Pelanda, R., & Torres, R. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092695 · Cited by 162
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J., Iwakura, Y., Metzger, D. W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902065 · Cited by 157
Majer, O., Bourgeois, C., Zwolanek, F., Lassnig, C., Kerjaschki, D., Mack, M., Müller, M., & Kuchler, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002811 · Cited by 156
Moseman, E. A., Iannacone, M., Bosurgi, L., Tonti, E., Chevrier, N., Tumanov, A. V., Fu, Y., Hacohen, N., & von Andrian, U. H. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.013 · Cited by 155
Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes
Stockinger, S., Materna, T., Stoiber, D., Bayr, L., Steinborn, R., Kolbe, T., Unger, H., Chakraborty, T., Levy, D. E., Müller, M. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6522 · Cited by 155
Streptococcus pneumoniae DNA Initiates Type I Interferon Signaling in the Respiratory Tract
Parker, D., Martin, F. J., Soong, G., Harfenist, B. S., Aguilar, J. L., Ratner, A. J., Fitzgerald, K. A., Schindler, C., & Prince, A. S. (2011) · mBio · doi:10.1128/mbio.00016-11 · Cited by 152
Martin, F. J., Gómez, M. I., Wetzel, D. M., Memmi, G., O’Seaghdha, M., Soong, G., Schindler, C., & Prince, A. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35879 · Cited by 151
Antiproliferative action of interferon-α requires components of T-cell-receptor signalling
Petricoin, E. F., Ito, S., Williams, B. L., Audet, S. A., Stancato, L. F., Gamero, A. M., Clouse, K. A., Grimley, P. M., Weiss, A., Beeler, J. A., et al. (1997) · Nature · doi:10.1038/37648 · Cited by 150
Spadaro, F., Lapenta, C., Donati, S., Abalsamo, L., Barnaba, V., Belardelli, F., Santini, S. M., & Ferrantini, M. (2011) · Blood · doi:10.1182/blood-2011-06-363564 · Cited by 150
Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-αβ Responses in T Lymphocytes
Tanabe, Y., Nishibori, T., Su, L., Arduini, R. M., Baker, D. P., & David, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.609 · Cited by 148
Privé, C., & Descoteaux, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8 · Cited by 148
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
OʼBrien, T. R., Prokunina‐Olsson, L., & Donnelly, R. P. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0136 · Cited by 147
Lee, C., Smith, E., Gimeno, R., Gertner, R., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1286 · Cited by 145
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
Navarini, A. A., Recher, M., Lang, K. S., Georgiev, P., Meury, S., Bergthaler, A., Flatz, L., Bille, J., Landmann, R., Odermatt, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607325103 · Cited by 144
Opitz, B., Vinzing, M., van Laak, V., Schmeck, B., Heine, G., Günther, S., Preißner, R., Slevogt, H., N’Guessan, P. D., Eitel, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604638200 · Cited by 142
Redford, P. S., Mayer-Barber, K. D., McNab, F. W., Stavropoulos, E., Wack, A., Sher, A., & O’Garra, A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit424 · Cited by 136
Self-citationLymphocytes are detrimental during the early innate immune response against Listeria monocytogenes
Carrero, J. A., Calderón, B., & Unanue, E. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060045 · Cited by 135
Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 133
Kelly‐Scumpia, K. M., Scumpia, P. O., Delano, M. J., Weinstein, J. S., Cuenca, A. G., Wynn, J. L., & Moldawer, L. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091959 · Cited by 132
Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Pucchio, T. D., Parlato, S., & Belardelli, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021924 · Cited by 128
Rothfuchs, A. G., Gigliotti, D., Palmblad, K., Andersson, U., Wigzell, H., & Rottenberg, M. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6453 · Cited by 128
Qiu, H., Fan, Y., Joyee, A. G., Wang, S., Han, X., Bai, H., Jiao, L., van Rooijen, N., & Yang, X. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2092 · Cited by 123
Shah, S., Bohsali, A., Ahlbrand, S. E., Srinivasan, L., Rathinam, V. A. K., Vogel, S. N., Fitzgerald, K. A., Sutterwala, F. S., & Briken, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301331 · Cited by 123
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121
Shigeno, M., Nakao, K., Ichikawa, T., Suzuki, K., Kawakami, A., Abiru, S., Miyazoe, S., Nakagawa, Y., Ishikawa, H., Hamasaki, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206139 · Cited by 117
Bourgeois, C., Majer, O., Frohner, I. E., Lesiak-Markowicz, I., Hildering, K.-S., Glaser, W., Stockinger, S., Decker, T., Akira, S., Müller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002599 · Cited by 116
Early type I interferon‐mediated signals on B cells specifically enhance antiviral humoral responses
Fink, K., Lang, K. S., Manjarrez‐Orduño, N., Junt, T., Senn, B. M., Holdener, M., Akira, S., Zinkernagel, R. M., & Hengartner, H. (2006) · European Journal of Immunology · doi:10.1002/eji.200635993 · Cited by 114
Kim, Y., Park, J., Reimer, T., Baker, D. P., Kawai, T., Kumar, H., Akira, S., Wobus, C. E., & Núñez, G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.05.006 · Cited by 113
The Role of Host Genetics in Susceptibility to Influenza: A Systematic Review
Horby, P., Nguyen, N., Dunstan, S. J., & Baillie, J. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033180 · Cited by 112
Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo
Gil, M. P., Salomon, R., Louten, J., & Biron, C. A. (2005) · Blood · doi:10.1182/blood-2005-07-2834 · Cited by 110
van Grevenynghe, J., Cubas, R. A., Noto, A., DaFonseca, S., He, Z., Peretz, Y., Filali-Mouhim, A., Dupuy, F. P., Procopio, F. A., Chomont, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59211 · Cited by 110
Characterization of the Interferon-Producing Cell in Mice Infected with Listeria monocytogenes
Stockinger, S., Kastner, R., Kernbauer, E., Pilz, A., Westermayer, S., Reutterer, B., Soulat, D., Stengl, G., Vogl, C., Frenz, T., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000355 · Cited by 108
Haque, A., Best, S. E., Ammerdorffer, A., Desbarrieres, L., de, M. M., Amante, F. H., Rivera, F. D. L., Hertzog, P. J., Boyle, G. M., Hill, G. R., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141539 · Cited by 107
Pinto, A. K., Daffis, S., Brien, J. D., Gainey, M. D., Yokoyama, W. M., Sheehan, K. C. F., MURPHY, K. M. M., Schreiber, R. D., & Diamond, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002407 · Cited by 107
Chi, B., Dickensheets, H. L., Spann, K. M., Alston, M. A., Luongo, C., Dumoutier, L., Huang, J., Renauld, J., Kotenko, S. V., Roederer, M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5032-5040.2006 · Cited by 106
Tschurtschenthaler, M., Wang, J., Fricke, C., Fritz, T. M. J., Niederreiter, L., Adolph, T. E., Sarcevic, E., Künzel, S., Offner, F. A., Kalinke, U., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305863 · Cited by 105
B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
Rau, F. C., Dieter, J. A., Luo, Z., Priest, S. O., & Baumgarth, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803783 · Cited by 105
Beta Interferon Controls West Nile Virus Infection and Pathogenesis in Mice
Lazear, H. M., Pinto, A. K., Vogt, M. R., Gale, M., & Diamond, M. (2011) · Journal of Virology · doi:10.1128/jvi.00396-11 · Cited by 104
Baranek, T., Manh, T. V., Alexandre, Y. O., Maqbool, M. A., Cabeza, J. Z., Tomasello, E., Crozat, K., Bessou, G., Zucchini, N., Robbins, S. H., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.002 · Cited by 103
Keppler, S. J., Rosenits, K., Kögl, T., Vucikuja, S., & Aichele, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040865 · Cited by 99
McNab, F. W., Ewbank, J., Rajsbaum, R., Stavropoulos, E., Մարտիրոսյան, Ա., Redford, P. S., Wu, X., Graham, C. M., Saraiva, M., Tsichlis, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300146 · Cited by 96
Self-citationType I IFN Receptor Regulates Neutrophil Functions and Innate Immunity to Leishmania Parasites
Xin, L., Vargas‐Inchaustegui, D. A., Raimer, S., Kelly, B. C., Hu, J., Zhu, L., Sun, J., & Soong, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903273 · Cited by 95
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Biondo, C., Signorino, G., Costa, A., Midiri, A., Gerace, E., Galbo, R., Bellantoni, A., Malara, A., Beninati, C., Teti, G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141490 · Cited by 94
Wang, J. O., Lin, Q., Langston, H. P., & Cooper, M. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90176-0 · Cited by 94
Marshall, H. D., Urban, S. L., & Welsh, R. M. (2011) · Journal of Virology · doi:10.1128/jvi.02516-10 · Cited by 93
Cutting Edge: IL-15-Independent NK Cell Response to Mouse Cytomegalovirus Infection
Sun, J. C.-Y., Ma, A., & Lanier, L. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901872 · Cited by 93
Kaser, A., Nagata, S., & Tilg, H. (1999) · Cytokine · doi:10.1006/cyto.1998.0484 · Cited by 91
Khouri, R., Báfica, A. L. B., da Silva, M. D. P. P., Noronha, A., Kolb, J., Wietzerbin, J., Barral, A. M. P., Barral‐Netto, M., & Weyenbergh, J. V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802860 · Cited by 88
Gil, M. P., Ploquin, M. J.-Y., Watford, W. T., Lee, S., Kim, K., Wang, X., Kanno, Y., O’Shea, J. J., & Biron, C. A. (2012) · Blood · doi:10.1182/blood-2012-05-428672 · Cited by 88
Santodonato, L., D’Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Perrone, M. P., Andreotti, M., Belardelli, F., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5195 · Cited by 86
TLR-Dependent Induction of IFN-β Mediates Host Defense against Trypanosoma cruzi
Koga, R., Hamano, S., Kuwata, H., Atarashi, K., Ogawa, M., Hisaeda, H., Yamamoto, M., Akira, S., Himeno, K., Matsumoto, M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7059 · Cited by 86
Interferons Direct an Effective Innate Response to Legionella pneumophila Infection
Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., & Schindler, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018283 · Cited by 85
Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-β Production
Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L., & Albina, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2125 · Cited by 85
Mack, E. A., Kallal, L. E., Demers, D. A., & Biron, C. A. (2011) · mBio · doi:10.1128/mbio.00169-11 · Cited by 85
de Almeida, L. A., Carvalho, N. B., Oliveira, F. S., Lacerda, T. L. S., Vasconcelos, A. C., Nogueira, L. D. L., Báfica, A. L. B., Silva, A. M., & Oliveira, S. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023135 · Cited by 84
Purtha, W. E., Chachu, K. A., Virgin, H. W., & Diamond, M. (2008) · Journal of Virology · doi:10.1128/jvi.01646-08 · Cited by 84
Voisine, C., Mastelic, B., Sponaas, A., & Langhorne, J. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.11.005 · Cited by 81
Schiavoni, G., Mauri, C., Carlei, D., Belardelli, F., Pastoris, M. C., & Proietti, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1266 · Cited by 79
Recombinant Human IFN-α Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice
Vigário, A. M., Belnoue, E., Grüner, A. C., Mauduit, M., Kayibanda, M., Deschemin, J., Marussig, M., Snounou, G., Mazier, D., Gresser, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6416 · Cited by 77
Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria
Tian, X., Xu, F., Lung, W. Y., Meyerson, C., Ghaffari, A. A., Cheng, G., & Deng, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041879 · Cited by 77
Ramos, H. J., Davis, A. M., Cole, A. G., Schatzle, J. D., Forman, J., & Farrar, J. D. (2009) · Blood · doi:10.1182/blood-2008-11-188458 · Cited by 75
Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN‐α
Rouzaut, A., Garasa, S., Teijeira, Á., González, I., Martínez‐Forero, I., Suárez, N., Larrea, E., Alfaro, C., Palazón, A., Dubrot, J., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040523 · Cited by 73
McNally, B. A., Ye, F., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.02423-13 · Cited by 72
Activation Mechanisms of Natural Killer Cells during Influenza Virus Infection
Hwang, I., Scott, J. M., Kakarla, T., Duriancik, D. M., Choi, S., Cho, C., Lee, T., Park, H., French, A. R., Beli, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051858 · Cited by 72
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 2,054
RIG-I-like receptors: their regulation and roles in RNA sensing
Rehwinkel, J., & Gack, M. U. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0288-3 · Cited by 1,770
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400
Metadata
- Authors
- McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- National Institutes of Health (US)
- National Institute for Medical Research (GB)
- Venue
- Nature Reviews Immunology
- Published
- 2015-01-23
- Volume
- 15
- Issue
- 2
- Pages
- 87-103
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7162685
- OpenAlex
- W2091129202
- Cited by
- 2,780
- References
- 238
- Citations by year
- 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (FC001126)
- Francis Crick Institute (10206, 10126)
- Cancer Research UK (FC001126)
- National Institutes of Health
- Medical Research Council (U117597139, U117565642)
- National Institute of Allergy and Infectious Diseases
- FP7 Ideas: European Research Council (294682)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
- MeSH terms
- Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review